| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neural Stem Cells | 12 | 2025 | 130 | 3.870 |
Why?
|
| Hippocampus | 19 | 2025 | 802 | 3.480 |
Why?
|
| Neurogenesis | 14 | 2025 | 220 | 2.600 |
Why?
|
| Metabolomics | 8 | 2023 | 500 | 1.910 |
Why?
|
| Neurons | 17 | 2023 | 2007 | 1.680 |
Why?
|
| Brain | 16 | 2026 | 3189 | 1.470 |
Why?
|
| Magnetic Resonance Spectroscopy | 9 | 2023 | 281 | 1.440 |
Why?
|
| Stem Cells | 8 | 2018 | 711 | 1.360 |
Why?
|
| Biomarkers | 7 | 2025 | 3397 | 0.940 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 3 | 2025 | 283 | 0.890 |
Why?
|
| Phagocytosis | 3 | 2020 | 189 | 0.890 |
Why?
|
| Organoids | 2 | 2024 | 306 | 0.850 |
Why?
|
| Astronauts | 1 | 2022 | 76 | 0.700 |
Why?
|
| Receptors, Notch | 3 | 2018 | 202 | 0.690 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 243 | 0.690 |
Why?
|
| Glycosyltransferases | 3 | 2018 | 27 | 0.680 |
Why?
|
| Radiation Injuries | 1 | 2022 | 145 | 0.680 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2024 | 3844 | 0.660 |
Why?
|
| Computational Biology | 1 | 2025 | 868 | 0.640 |
Why?
|
| Animals | 34 | 2025 | 33899 | 0.570 |
Why?
|
| Drosophila melanogaster | 2 | 2023 | 848 | 0.560 |
Why?
|
| Nerve Regeneration | 2 | 2020 | 75 | 0.540 |
Why?
|
| Astrocytes | 5 | 2023 | 282 | 0.490 |
Why?
|
| Models, Neurological | 1 | 2017 | 208 | 0.480 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 203 | 0.480 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2024 | 64 | 0.470 |
Why?
|
| Microglia | 2 | 2020 | 140 | 0.470 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 264 | 0.450 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2016 | 92 | 0.440 |
Why?
|
| Mice | 20 | 2025 | 18224 | 0.440 |
Why?
|
| Adult Stem Cells | 2 | 2021 | 51 | 0.420 |
Why?
|
| Dendrites | 5 | 1999 | 183 | 0.420 |
Why?
|
| Systems Biology | 2 | 2011 | 60 | 0.400 |
Why?
|
| Apoptosis | 4 | 2020 | 1849 | 0.390 |
Why?
|
| Energy Metabolism | 1 | 2018 | 796 | 0.380 |
Why?
|
| Antidepressive Agents | 3 | 2024 | 327 | 0.370 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 288 | 0.360 |
Why?
|
| Mass Spectrometry | 3 | 2024 | 364 | 0.350 |
Why?
|
| Molecular Imaging | 2 | 2024 | 60 | 0.350 |
Why?
|
| Humans | 40 | 2026 | 130574 | 0.350 |
Why?
|
| Rett Syndrome | 2 | 2025 | 228 | 0.340 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 153 | 0.340 |
Why?
|
| Cell Differentiation | 8 | 2023 | 1921 | 0.340 |
Why?
|
| Single-Cell Analysis | 3 | 2025 | 360 | 0.320 |
Why?
|
| Pyramidal Cells | 4 | 2017 | 151 | 0.320 |
Why?
|
| Lipids | 2 | 2017 | 564 | 0.320 |
Why?
|
| Cognition | 2 | 2022 | 816 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 4701 | 0.320 |
Why?
|
| Signal Transduction | 4 | 2018 | 4665 | 0.300 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 2340 | 0.290 |
Why?
|
| Exocytosis | 2 | 1998 | 66 | 0.280 |
Why?
|
| Brain Chemistry | 2 | 2024 | 111 | 0.280 |
Why?
|
| Intelligence | 1 | 2008 | 103 | 0.270 |
Why?
|
| Glutathione | 2 | 2018 | 199 | 0.250 |
Why?
|
| Kidney | 2 | 2024 | 1283 | 0.250 |
Why?
|
| Aging | 3 | 2021 | 1252 | 0.230 |
Why?
|
| Liver | 2 | 2024 | 1802 | 0.230 |
Why?
|
| Schizophrenia | 1 | 2008 | 326 | 0.230 |
Why?
|
| Cell Proliferation | 6 | 2022 | 2468 | 0.220 |
Why?
|
| Fatty Acids | 1 | 2007 | 377 | 0.220 |
Why?
|
| Demyelinating Diseases | 1 | 2005 | 69 | 0.220 |
Why?
|
| Polysomnography | 1 | 2026 | 156 | 0.220 |
Why?
|
| Duloxetine Hydrochloride | 1 | 2024 | 15 | 0.210 |
Why?
|
| Central Nervous System Diseases | 1 | 2005 | 98 | 0.210 |
Why?
|
| Glutamic Acid | 2 | 2016 | 209 | 0.210 |
Why?
|
| Multiple Sclerosis | 2 | 2024 | 389 | 0.210 |
Why?
|
| Polyadenylation | 1 | 2024 | 47 | 0.200 |
Why?
|
| Cluster Analysis | 2 | 2023 | 417 | 0.200 |
Why?
|
| Calcium | 2 | 1998 | 1034 | 0.200 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 232 | 0.200 |
Why?
|
| Spleen | 1 | 2024 | 255 | 0.200 |
Why?
|
| Fluorescent Dyes | 4 | 2018 | 248 | 0.190 |
Why?
|
| Sleep Wake Disorders | 1 | 2026 | 205 | 0.190 |
Why?
|
| Sleep | 1 | 2026 | 373 | 0.190 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 13 | 0.190 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 160 | 0.190 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2013 | 48 | 0.180 |
Why?
|
| Oleic Acid | 1 | 2022 | 17 | 0.180 |
Why?
|
| Radiation Protection | 1 | 2022 | 49 | 0.180 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2024 | 142 | 0.180 |
Why?
|
| Cells, Cultured | 7 | 2018 | 2903 | 0.180 |
Why?
|
| Gene Duplication | 1 | 2023 | 361 | 0.180 |
Why?
|
| Radiation Exposure | 1 | 2022 | 44 | 0.180 |
Why?
|
| Algorithms | 4 | 2024 | 1680 | 0.180 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2021 | 63 | 0.170 |
Why?
|
| Antigens, Differentiation | 1 | 2021 | 64 | 0.170 |
Why?
|
| Biology | 1 | 2021 | 25 | 0.170 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 56 | 0.170 |
Why?
|
| Rats | 7 | 2020 | 3412 | 0.160 |
Why?
|
| Embryonic Stem Cells | 2 | 2014 | 158 | 0.160 |
Why?
|
| Adult | 11 | 2025 | 31202 | 0.160 |
Why?
|
| Microsomes, Liver | 1 | 2020 | 96 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 273 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2026 | 620 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 326 | 0.150 |
Why?
|
| Kainic Acid | 2 | 2016 | 22 | 0.150 |
Why?
|
| Pseudopodia | 1 | 1999 | 7 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 3 | 2021 | 1090 | 0.150 |
Why?
|
| Models, Animal | 1 | 2021 | 457 | 0.150 |
Why?
|
| Space Flight | 1 | 2022 | 169 | 0.150 |
Why?
|
| Transcriptome | 2 | 2022 | 1132 | 0.140 |
Why?
|
| Golgi Apparatus | 1 | 1998 | 92 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1999 | 134 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 107 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 988 | 0.140 |
Why?
|
| Mutation | 3 | 2023 | 6139 | 0.140 |
Why?
|
| Long-Term Potentiation | 1 | 1998 | 105 | 0.140 |
Why?
|
| Cell Cycle | 2 | 2017 | 595 | 0.140 |
Why?
|
| Apolipoproteins D | 1 | 2017 | 4 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 240 | 0.130 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2017 | 36 | 0.130 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2008 | 123 | 0.130 |
Why?
|
| Apolipoprotein E4 | 1 | 2017 | 52 | 0.130 |
Why?
|
| Fluorometry | 1 | 2017 | 27 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 4 | 2010 | 367 | 0.130 |
Why?
|
| Lipid Droplets | 1 | 2017 | 52 | 0.130 |
Why?
|
| Organ of Corti | 1 | 2016 | 26 | 0.130 |
Why?
|
| Glycolysis | 1 | 2018 | 174 | 0.130 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2016 | 10 | 0.130 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2016 | 17 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 289 | 0.120 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2016 | 13 | 0.120 |
Why?
|
| Receptors, CCR2 | 1 | 2016 | 23 | 0.120 |
Why?
|
| Receptors, Chemokine | 1 | 2016 | 47 | 0.120 |
Why?
|
| Synapses | 2 | 1999 | 448 | 0.120 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 84 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 337 | 0.120 |
Why?
|
| Male | 14 | 2026 | 64557 | 0.120 |
Why?
|
| Sindbis Virus | 2 | 2010 | 10 | 0.120 |
Why?
|
| Entorhinal Cortex | 1 | 2015 | 23 | 0.120 |
Why?
|
| Neuroglia | 1 | 2017 | 222 | 0.110 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2015 | 31 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 587 | 0.110 |
Why?
|
| Amino Acids | 1 | 2018 | 566 | 0.110 |
Why?
|
| Psychomotor Agitation | 1 | 2015 | 54 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2016 | 81 | 0.110 |
Why?
|
| Proteins | 2 | 2018 | 1006 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 517 | 0.110 |
Why?
|
| Thalamus | 1 | 2015 | 85 | 0.110 |
Why?
|
| Potassium Channels | 1 | 1995 | 156 | 0.110 |
Why?
|
| Monocytes | 1 | 2016 | 335 | 0.100 |
Why?
|
| HMGB2 Protein | 1 | 2013 | 2 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 214 | 0.100 |
Why?
|
| Intestines | 1 | 2018 | 591 | 0.100 |
Why?
|
| Homeostasis | 1 | 2018 | 715 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2016 | 496 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 31 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 32 | 0.100 |
Why?
|
| Thinking | 1 | 2013 | 34 | 0.100 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 63 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 2013 | 111 | 0.090 |
Why?
|
| Visual Cortex | 1 | 2014 | 130 | 0.090 |
Why?
|
| Models, Biological | 1 | 2017 | 1390 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 323 | 0.090 |
Why?
|
| Language Development Disorders | 1 | 2013 | 177 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1558 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2013 | 519 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2013 | 389 | 0.080 |
Why?
|
| Seizures | 1 | 2016 | 886 | 0.080 |
Why?
|
| Electroencephalography | 2 | 2026 | 858 | 0.080 |
Why?
|
| Metabolome | 1 | 2013 | 324 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2016 | 709 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1601 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2011 | 257 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 1592 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2010 | 167 | 0.080 |
Why?
|
| Base Sequence | 1 | 2013 | 2745 | 0.070 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 279 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2026 | 5085 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2343 | 0.070 |
Why?
|
| Female | 12 | 2026 | 70509 | 0.070 |
Why?
|
| Age of Onset | 2 | 2024 | 596 | 0.070 |
Why?
|
| Child | 6 | 2026 | 26145 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 340 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2014 | 901 | 0.070 |
Why?
|
| Epilepsy | 1 | 2015 | 879 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2011 | 557 | 0.070 |
Why?
|
| Glucosyltransferases | 2 | 2018 | 44 | 0.070 |
Why?
|
| Hair Follicle | 1 | 2007 | 32 | 0.070 |
Why?
|
| Protons | 1 | 2007 | 98 | 0.060 |
Why?
|
| Adolescent | 4 | 2026 | 20774 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2018 | 689 | 0.060 |
Why?
|
| Young Adult | 4 | 2025 | 9991 | 0.060 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2015 | 858 | 0.060 |
Why?
|
| Sleep Stages | 1 | 2026 | 31 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2008 | 302 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3835 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2026 | 14987 | 0.050 |
Why?
|
| Activation, Metabolic | 1 | 2024 | 4 | 0.050 |
Why?
|
| Prosencephalon | 1 | 2024 | 41 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 364 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2026 | 234 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 13 | 0.050 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2022 | 19 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2022 | 27 | 0.050 |
Why?
|
| White Matter | 1 | 2024 | 218 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3413 | 0.050 |
Why?
|
| Luminescent Proteins | 2 | 1999 | 143 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 418 | 0.040 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2020 | 16 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 488 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 517 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1124 | 0.040 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2020 | 5 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2020 | 152 | 0.040 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2020 | 11 | 0.040 |
Why?
|
| Synaptic Transmission | 2 | 1999 | 323 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2020 | 79 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2020 | 66 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 1999 | 16 | 0.040 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1999 | 14 | 0.040 |
Why?
|
| Culture Techniques | 1 | 1999 | 72 | 0.040 |
Why?
|
| Synaptic Membranes | 1 | 1999 | 23 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2020 | 121 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2020 | 340 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2018 | 46 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1998 | 34 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 1998 | 27 | 0.040 |
Why?
|
| Organelles | 1 | 1998 | 22 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1999 | 94 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 1999 | 240 | 0.030 |
Why?
|
| Microscopy | 1 | 1999 | 118 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2020 | 245 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 1999 | 809 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1999 | 191 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 315 | 0.030 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2017 | 11 | 0.030 |
Why?
|
| Apolipoprotein E2 | 1 | 2017 | 16 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 434 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 1998 | 138 | 0.030 |
Why?
|
| Cell Count | 1 | 2017 | 214 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 105 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2932 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 413 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 232 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2026 | 17653 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 324 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2016 | 53 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 1136 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 230 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 300 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2015 | 231 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 1087 | 0.030 |
Why?
|
| Phosphocreatine | 1 | 2015 | 6 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 840 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 179 | 0.030 |
Why?
|
| Creatine | 1 | 2015 | 39 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 254 | 0.030 |
Why?
|
| Atrophy | 1 | 2015 | 243 | 0.030 |
Why?
|
| Sample Size | 1 | 2015 | 85 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 151 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 204 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1995 | 291 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 680 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1575 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2013 | 18 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6475 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 623 | 0.030 |
Why?
|
| Telomerase | 1 | 2014 | 155 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 292 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 603 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 121 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 427 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1995 | 450 | 0.020 |
Why?
|
| Axons | 1 | 2016 | 388 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 832 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 304 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 3702 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1010 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2571 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1995 | 1017 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1387 | 0.020 |
Why?
|
| Fetus | 1 | 1995 | 584 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 680 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1214 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 2844 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 761 | 0.020 |
Why?
|
| Gene Expression | 1 | 1995 | 1489 | 0.020 |
Why?
|
| Middle Aged | 3 | 2015 | 28448 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 1683 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3487 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3413 | 0.020 |
Why?
|
| Nestin | 1 | 2007 | 14 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2007 | 21 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1728 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2007 | 125 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 152 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 3053 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2010 | 900 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4664 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6773 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 8553 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 1843 | 0.010 |
Why?
|
| Dissection | 1 | 1999 | 58 | 0.010 |
Why?
|
| Photons | 1 | 1999 | 62 | 0.010 |
Why?
|
| Lasers | 1 | 1999 | 113 | 0.010 |
Why?
|
| Equipment Design | 1 | 1999 | 546 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 20925 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 690 | 0.010 |
Why?
|